These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
91 related articles for article (PubMed ID: 24036038)
1. Validation of a specific prolylcarboxypeptidase activity assay and its suitability for plasma and serum measurements. Kehoe K; Verkerk R; Sim Y; Waumans Y; Van der Veken P; Lambeir AM; De Meester I Anal Biochem; 2013 Dec; 443(2):232-9. PubMed ID: 24036038 [TBL] [Abstract][Full Text] [Related]
2. Prolyl carboxypeptidase activity in the circulation and its correlation with body weight and adipose tissue in lean and obese subjects. Kehoe K; Noels H; Theelen W; De Hert E; Xu S; Verrijken A; Arnould T; Fransen E; Hermans N; Lambeir AM; Venge P; Van Gaal L; De Meester I PLoS One; 2018; 13(5):e0197603. PubMed ID: 29772029 [TBL] [Abstract][Full Text] [Related]
3. Dysregulation of the renin-angiotensin system during lung ischemia-reperfusion injury. Kehoe K; Gielis JF; Vliegen G; Van Elzen R; Verkerk R; Driessens E; Domen A; Lambeir AM; Maes L; Cos P; De Meester I; Van Schil PE Exp Lung Res; 2016 Aug; 42(6):277-85. PubMed ID: 27437782 [TBL] [Abstract][Full Text] [Related]
5. Prolylcarboxypeptidase (PrCP) inhibitors and the therapeutic uses thereof: a patent review. Graham TH Expert Opin Ther Pat; 2017 Oct; 27(10):1077-1088. PubMed ID: 28699813 [TBL] [Abstract][Full Text] [Related]
6. Proline-specific peptidase activities (DPP4, PRCP, FAP and PREP) in plasma of hospitalized COVID-19 patients. Bracke A; De Hert E; De Bruyn M; Claesen K; Vliegen G; Vujkovic A; van Petersen L; De Winter FHR; Hotterbeekx A; Brosius I; Theunissen C; Van Ierssel S; van Frankenhuijsen M; Vlieghe E; Vercauteren K; Van der Veken P; Hendriks D; Kumar-Singh S; De Meester I Clin Chim Acta; 2022 Jun; 531():4-11. PubMed ID: 35283094 [TBL] [Abstract][Full Text] [Related]
7. Plasma prolylcarboxypeptidase (angiotensinase C) is increased in obesity and diabetes mellitus and related to cardiovascular dysfunction. Xu S; Lind L; Zhao L; Lindahl B; Venge P Clin Chem; 2012 Jul; 58(7):1110-5. PubMed ID: 22539806 [TBL] [Abstract][Full Text] [Related]
8. Prolyl carboxypeptidase activity decline correlates with severity and short-term outcome in acute ischemic stroke. Kehoe K; Brouns R; Verkerk R; Engelborghs S; De Deyn PP; Hendriks D; De Meester I Neurochem Res; 2015 Jan; 40(1):81-8. PubMed ID: 25370794 [TBL] [Abstract][Full Text] [Related]
9. Highly selective hydrolysis of kinins by recombinant prolylcarboxypeptidase. Chajkowski SM; Mallela J; Watson DE; Wang J; McCurdy CR; Rimoldi JM; Shariat-Madar Z Biochem Biophys Res Commun; 2011 Feb; 405(3):338-43. PubMed ID: 21167814 [TBL] [Abstract][Full Text] [Related]
10. Peptidomic profiling of human cerebrospinal fluid identifies YPRPIHPA as a novel substrate for prolylcarboxypeptidase. Zhao X; Southwick K; Cardasis HL; Du Y; Lassman ME; Xie D; El-Sherbeini M; Geissler WM; Pryor KD; Verras A; Garcia-Calvo M; Shen DM; Yates NA; Pinto S; Hendrickon RC Proteomics; 2010 Aug; 10(15):2882-6. PubMed ID: 20517885 [TBL] [Abstract][Full Text] [Related]
11. High-performance liquid chromatographic determination of prolylcarboxypeptidase activity in monkey kidney. Suzawa Y; Hiraoka BY; Harada M; Deguchi T J Chromatogr B Biomed Appl; 1995 Aug; 670(1):152-6. PubMed ID: 7493073 [TBL] [Abstract][Full Text] [Related]
12. Development of a sensitive and selective assay for the determination of procarboxypeptidase U (thrombin-activatable fibrinolysis inhibitor) in plasma. Heylen E; Van Goethem S; Willemse J; Olsson T; Augustyns K; Hendriks D Anal Biochem; 2010 Jan; 396(1):152-4. PubMed ID: 19732738 [TBL] [Abstract][Full Text] [Related]
13. Overexpression of prolylcarboxypeptidase enhances plasma prekallikrein activation on Chinese hamster ovary cells. Shariat-Madar Z; Rahimy E; Mahdi F; Schmaier AH Am J Physiol Heart Circ Physiol; 2005 Dec; 289(6):H2697-703. PubMed ID: 16113074 [TBL] [Abstract][Full Text] [Related]
15. Structural definition and substrate specificity of the S28 protease family: the crystal structure of human prolylcarboxypeptidase. Soisson SM; Patel SB; Abeywickrema PD; Byrne NJ; Diehl RE; Hall DL; Ford RE; Reid JC; Rickert KW; Shipman JM; Sharma S; Lumb KJ BMC Struct Biol; 2010 Jun; 10():16. PubMed ID: 20540760 [TBL] [Abstract][Full Text] [Related]
16. Purification and characterization of a Z-pro-prolinal-insensitive Z-Gly-Pro-7-amino-4-methyl coumarin-hydrolyzing peptidase from bovine serum--a new proline-specific peptidase. Birney YA; O'Connor BF Protein Expr Purif; 2001 Jul; 22(2):286-98. PubMed ID: 11437605 [TBL] [Abstract][Full Text] [Related]
17. A highly sensitive and selective method for the determination of leukotriene B4 (LTB4) in ex vivo stimulated human plasma by ultra fast liquid chromatography-tandem mass spectrometry. Lin W; Huang MQ; Xue X; Bertelsen K; Chen G; Zhao H; Lin ZJ; Fourie A; de Jong J; Weng N J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Apr; 925():54-62. PubMed ID: 23523878 [TBL] [Abstract][Full Text] [Related]
18. Increased Prolylcarboxypeptidase Expression Can Serve as a Biomarker of Senescence in Culture. Boullard NG; Paris JJ; Shariat-Madar Z; Mahdi F Molecules; 2024 May; 29(10):. PubMed ID: 38792081 [TBL] [Abstract][Full Text] [Related]